{"id":"https://openalex.org/W2402717153","doi":null,"title":"Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.","display_name":"Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.","publication_year":2002,"publication_date":"2002-07-01","ids":{"openalex":"https://openalex.org/W2402717153","mag":"2402717153","pmid":"https://pubmed.ncbi.nlm.nih.gov/12243375"},"language":"en","primary_location":{"id":"pmid:12243375","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12243375","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of nephrology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066146703","display_name":"Roberto Pisoni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Roberto Pisoni","raw_affiliation_strings":["Mario Negri Institute for Pharmacological Research, Unit of Nephrology and Dialysis, Ospedali Riuniti di Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mario Negri Institute for Pharmacological Research, Unit of Nephrology and Dialysis, Ospedali Riuniti di Bergamo, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062602374","display_name":"Rita Faraone","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rita Faraone","raw_affiliation_strings":["Laboratori Negri Bergamo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratori Negri Bergamo","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031092149","display_name":"Piero Ruggenent","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Piero Ruggenent","raw_affiliation_strings":["Laboratori Negri Bergamo"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratori Negri Bergamo","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023556434","display_name":"Giuseppe Remuzzi","orcid":"https://orcid.org/0000-0002-6194-3446","observed_orcids":["https://orcid.org/0000-0002-6194-3446"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Remuzzi","raw_affiliation_strings":["Istituto di Ricerche Farmacologiche Mario Negri;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche Mario Negri;","institution_ids":["https://openalex.org/I19630809"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.5746,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.84113166,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"15","issue":"4","first_page":"428","last_page":"30"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9541000127792358,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.9541000127792358,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.03099999949336052,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.007000000216066837,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/renin-angiotensin-system-inhibitors","display_name":"renin-angiotensin system inhibitors","score":0.9919999837875366},{"id":"https://openalex.org/keywords/severe-renal-insufficiency","display_name":"severe renal insufficiency","score":0.7770000100135803},{"id":"https://openalex.org/keywords/end-stage-renal-disease","display_name":"end-stage renal disease","score":0.8399999737739563},{"id":"https://openalex.org/keywords/glomerular-filtration-rate-decline","display_name":"glomerular filtration rate decline","score":0.9909999966621399},{"id":"https://openalex.org/keywords/renal-protection","display_name":"renal protection","score":0.9509999752044678},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9629999995231628},{"id":"https://openalex.org/keywords/acute-kidney-injury","display_name":"acute kidney injury","score":0.6029999852180481},{"id":"https://openalex.org/keywords/hyperkalemia","display_name":"hyperkalemia","score":0.9900000095367432},{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":0.7620000243186951},{"id":"https://openalex.org/keywords/ramipril","display_name":"ramipril","score":0.9240000247955322}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9605798721313477},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.6889550089836121},{"id":"https://openalex.org/C2779888176","wikidata":"https://www.wikidata.org/wiki/Q412666","display_name":"Ramipril","level":3,"score":0.6530069708824158},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6374983787536621},{"id":"https://openalex.org/C2779922275","wikidata":"https://www.wikidata.org/wiki/Q1129105","display_name":"Diabetic nephropathy","level":3,"score":0.5711026191711426},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4528083801269531},{"id":"https://openalex.org/C2779561371","wikidata":"https://www.wikidata.org/wiki/Q570197","display_name":"Proteinuria","level":3,"score":0.4513423442840576},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.45072343945503235},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.44386571645736694},{"id":"https://openalex.org/C2781184683","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Nephropathy","level":3,"score":0.4365561306476593},{"id":"https://openalex.org/C2778653478","wikidata":"https://www.wikidata.org/wiki/Q1054718","display_name":"Kidney disease","level":2,"score":0.41802069544792175},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.37741339206695557},{"id":"https://openalex.org/C2780091579","wikidata":"https://www.wikidata.org/wiki/Q9377","display_name":"Kidney","level":2,"score":0.2262357473373413},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.18978506326675415}],"mesh":[{"descriptor_ui":"D000806","descriptor_name":"Angiotensin-Converting Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003928","descriptor_name":"Diabetic Nephropathies","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005919","descriptor_name":"Glomerular Filtration Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012084","descriptor_name":"Renin-Angiotensin System","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D012680","descriptor_name":"Sensitivity and Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017257","descriptor_name":"Ramipril","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018849","descriptor_name":"Controlled Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:12243375","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12243375","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of nephrology","raw_type":"Journal Article"},{"id":"mag:2402717153","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12243375","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2100124500","https://openalex.org/W2146658619","https://openalex.org/W2617319984","https://openalex.org/W1989863808","https://openalex.org/W2588872768","https://openalex.org/W2755751681","https://openalex.org/W2138670606","https://openalex.org/W2124871448","https://openalex.org/W4399767475","https://openalex.org/W2144722247"],"abstract_inverted_index":{"Drugs":[0],"that":[1,32,107,204],"inhibit":[2],"the":[3,12,24,60,71,92,149,156,180,220],"renin-angiotensin":[4],"system":[5],"(RAS)":[6],"are":[7],"of":[8,14,59,62,91,151,182,186,219,222],"proven":[9],"benefit":[10],"in":[11,39,55,125,129,148,153,162],"treatment":[13],"hypertension,":[15],"congestive":[16],"heart":[17],"failure,":[18],"or":[19],"acute":[20,63],"myocardial":[21],"infarction.":[22],"In":[23,95],"last":[25],"decade,":[26],"several":[27],"clinical":[28,169],"trials":[29,57],"have":[30,144],"shown":[31,147],"RAS":[33,108,175,205],"inhibitors":[34],"also":[35,145],"offer":[36,78],"significant":[37],"renoprotection":[38],"both":[40],"diabetic":[41],"and":[42,67,118,171],"non-diabetic":[43],"nephropathy.":[44],"However,":[45],"patients":[46,82,101,130,163,213],"with":[47,83,102,155,164,214],"advanced":[48],"renal":[49,64,85,104,122,172,223],"insufficiency":[50],"did":[51],"not":[52,77],"take":[53],"part":[54],"these":[56,79,201],"because":[58],"risk":[61,181],"failure":[65],"(ARF)":[66],"hyperkalemia,":[68],"and,":[69],"for":[70],"same":[72],"reason,":[73],"most":[74],"physicians":[75],"do":[76],"drugs":[80],"to":[81,120,133,138,196,211],"impaired":[84],"function.":[86,224],"Recently,":[87],"a":[88,126],"post-hoc":[89],"analysis":[90],"Ramipril":[93],"Efficacy":[94],"Nephropathy":[96],"(REIN)":[97],"study":[98],"which":[99],"included":[100],"severe":[103],"insufficiency,":[105,173],"showed":[106],"inhibition":[109,176,206],"slows":[110],"glomerular":[111],"filtration":[112],"rate":[113],"(GFR)":[114],"decline":[115],"over":[116],"time":[117],"progression":[119],"end-stage":[121],"disease":[123],"(ESRD)":[124],"safe":[127],"way":[128],"quite":[131],"close":[132],"ESRD":[134,183],"(basal":[135],"GFR,":[136],"10":[137],"30":[139],"ml/min/1.73m2).":[140],"These":[141],"beneficial":[142],"effects":[143],"been":[146,192],"Reduction":[150],"Endpoints":[152],"NIDDM":[154],"All":[157],"Antagonist":[158],"Losartan":[159],"(RENAAL)":[160],"study,":[161],"type":[165],"2":[166],"diabetes":[167],"mellitus,":[168],"proteinuria,":[170],"where":[174],"therapy":[177,207],"significantly":[178],"reduced":[179],"once":[184],"doubling":[185],"baseline":[187],"serum":[188],"creatinine":[189],"levels":[190],"had":[191],"achieved":[193],"as":[194],"compared":[195],"non-RAS":[197],"anti-hypertensive":[198],"treatment.":[199],"Thus,":[200],"data":[202],"suggest":[203],"should":[208],"be":[209],"given":[210],"all":[212],"proteinuric":[215],"chronic":[216],"nephropathy,":[217],"independently":[218],"level":[221]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}